Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 80.00
+0.50 (0.63%)
Sep 30, 2026, 12:49 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 123.65 billion as of September 29, 2026. Its market cap has decreased by -56.79% in one year.
Market Cap
123.65B
Enterprise Value
119.72B
Revenue
29.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
80.00
ChartMarket Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 123.65B, an increase of 1,453.76%. That is a compound annual growth rate of 107.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 123.65B | -48.53% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 164.18B |
| Pell Bio-Med Technology | 64.47B |
| CHO Pharma | 25.68B |
| Sunmax Biotechnology | 21.76B |
| Oneness Biotech | 21.46B |
| Medigen Vaccine Biologics | 19.66B |
| TaiMed Biologics | 16.97B |
| Gongwin Biopharm Holdings | 16.59B |